DLL3/CD3/CD137 trispecific T cell engager(Chugai Pharmaceutical)

DLL3/CD3/CD137三特异性抗体(中外制药)

Report date: 2026/03/19 17:16:14

Base Information

Drug NameDLL3/CD3/CD137 trispecific T cell engager(Chugai Pharmaceutical)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-Delta-like protein 3Anti-CD3Anti-Tumor necrosis factor receptor superfamily member 9

TargetsDelta-like protein 3T cell surface glycoprotein CD3Tumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsSmall Cell Lung Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChugai Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A